Philippe Carteron de Balmont

Philippe Carteron de Balmont

  • Orphan Drugs
  • General Director and Founder
  • CARTHAGENETICSĀ®
  • Switzerland
Title :

Abstract :

Biography:

Philippe holds master’s in biology and in Pharmaceutical Marketing (Institute Superior de Gestion, Paris 16e). He has been working for more than 20 years in biotech companies in the European, Middle East et North Africa Orphan Drugs market, at country manager levels with "pre-launch" and "launch" of major Orphan Drugs (for Genzyme, TKT / Shire, BioMarin, Alexion, FoldRx / Pfizer) etc...

Philippe has proven track record of key negotiations with government bodies, including Health and Social ministers, regulatory agencies and patient associations and has been participating in policy development and implementation for Orphan Drugs, notably in Turkey. His last studies (Executive master’s in international Negotiation & Policy Making, The Graduate Institute (IHEID), Geneva 2009) have given him further tools that have enabled him to broaden the skills developed over last years.

Research Interest
He has been working for more than 20 years in biotech companies in the European, Middle East et North Africa Orphan Drugs market, at country manager levels with "pre-launch" and "launch" of major Orphan Drugs (for Genzyme, TKT / Shire, BioMarin, Alexion,

Join Our Newsletter